REFERENCES
- Wilson WR, Karchmer AW, Dajani A et al. Antibiotic treatment of adults with infective endocarditis due to strepto-cocci, enterococci, staphylococci, and HACEK microorgani-sms. JAMA1995; 274: 1706–1713.
- Horodniceanu T, Bougueleret L, El-Solh N, Bieth G, Delbos F. High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother 1979; 16: 686–689.
- Cercenado E, Eliopoulos GM, Wennersten CB, Moellering RCJr. Influence of high-level gentamicin resistan-ce and beta-haemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin. Antimicrob Agents Chemother 1992; 36: 2526–2528.
- Eliopoulos GM, Wennersten C, Zighelboim-Daum S, Reiszner S, Goldman F, Moellering RCJr. High-level resistan-ce to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother 1988; 32: 1528–1532.
- Eliopoulos GM. Antibiotic resistance in Enterococcus species: an update. In J.S. Remington, and M.N. Swartz (ed.), Current clinical topics in infectious diseases. Boston, Mass: Blackwell Science, Inc., 1996: 21-51.
- Mainardi JL, Gutmann L, Acar F, Goldstein FW. Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother 1995; 39: 1984–1987.
- GayaIda J, Torres C, Tenorio C et al. Efficacy of ampi-cillin plus ceftriaxone in treatment of experimental endocardi-tis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother 1999; 43: 639–646.
- Venditti M, Brandimarte C, Capone A, et al. Endocarditis caused by an Enterococcus faecalis high-level resistant to aminoglycosides: failure of ampicillin and ceftriaxo-ne combined therapy. Clin Microbiol Infect 1997; 3: 577–80.
- GayaIda in Program and abstract of the sixth International symposium on modern concepts in endocarditis and cardiovascular infections, Sitges, Spain, 2001.
- Tascini C, Tagliaferri E, Iapoce R, Leonildi A, Menichetti F. Caspofungin in combination with itraconazole and amphotericin B for the treatment of invasive Aspergillosis in humans, with a method to test ex vivo synergism. Clin Microbiol Infect 2003; 9: 901–2.
- Tascini C, Gemignani G, Leonildi A, Menichetti F. “Ex vivo” synergism: a method to optimise antimicrobial combina-tions for difficult-to-treat enterococcal endocarditis. J Chemother 2003; 15: 613–5.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically, 4th ed. Document M7-A4. National Committee for Clinical Laboratory Standards, Villanova, PA. 1997.
- National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline. Document M26-P. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1987.
- National Committee for Clinical Laboratory Standards. Methodology for the serum bactericidal test. Document M-21A. National Committee for Clinical Laboratory Standards, Villanova, PA. 1999.
- Rice LB, Calderwood SB, Eliopoulos GM, Farber BF, Karchmer AW. Enterococcal endocarditis: a comparison of prosthetic and native valve diseases. Rev Infect Dis 1991; 13: 1–7.